Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S8KA
|
||||
Former ID |
DNC004125
|
||||
Drug Name |
3-(2-Amino-propyl)-1H-indol-5-ol
|
||||
Synonyms |
5-hydroxy-alpha-methyltryptamine
|
||||
Indication | Discovery agent | Investigative | [527952] | ||
Structure |
Download2D MOL |
||||
Canonical SMILES |
CC(CC1=CNC2=C1C=C(C=C2)O)N
|
||||
InChI |
1S/C11H14N2O/c1-7(12)4-8-6-13-11-3-2-9(14)5-10(8)11/h2-3,5-7,13-14H,4,12H2,1H3
|
||||
InChIKey |
LYPCGXKCQDYTFV-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527952] | |
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527952] | ||
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527952] | ||
5-hydroxytryptamine 1A receptor | Target Info | Inhibitor | [526713] | ||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | ||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP722:Serotonin HTR1 Group and FOS Pathway | |||||
References | |||||
Ref 526713 | J Med Chem. 2003 Sep 11;46(19):4188-95.A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole. | ||||
Ref 527952 | J Med Chem. 2006 Jan 12;49(1):318-28.1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.